aTYR PHARMA INC Lessee, Operating Lease, Discount Rate
aTYR PHARMA INC (ATYR) had Lessee, Operating Lease, Discount Rate of 9.60% as of 2019-12-31, per its 10-K filed 2020-03-26.
Discontinued › Notes › Leases
us-gaap:LesseeOperatingLeaseDiscountRate · last filed 2020-03-26
- 2019-12-31: Lessee, Operating Lease, Discount Rate 9.60%.
- 2019-09-30: Lessee, Operating Lease, Discount Rate 9.60%.
- 2019-06-30: Lessee, Operating Lease, Discount Rate 9.60%.
- 2019-03-31: Lessee, Operating Lease, Discount Rate 9.60%.
| Period end | Lessee, Operating Lease, Discount Rate |
|---|---|
| 2019-12-31 | 9.60% 10-K · filed 2020-03-26 |
| 2019-09-30 | 9.60% 10-Q · filed 2019-11-14 |
| 2019-06-30 | 9.60% 10-Q · filed 2019-08-14 |
| 2019-03-31 | 9.60% 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |